The HypoFocal-SBRT study was designed to investigate the individualization of RT based on patient specific tumor morphology derived from mpMRI and PSMA-PET for unfavorable-intermediate and high-risk PCa patients. The gene discussed is FOLH1; the disease is posterior cortical atrophy.